What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage
WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. · fever · cough · shortness of breath · swelling of arms and legs · fast weight gain (greater than 10 pounds within a week) · bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m